A multicentre, multinational, randomised, open study to establish the optimal method for initiating Lantus (insulin glargine) therapy to determine metabolic and economic outcomes, safety, and satisfaction in subjects with type 2 diabetes mellitus.

Trial Profile

A multicentre, multinational, randomised, open study to establish the optimal method for initiating Lantus (insulin glargine) therapy to determine metabolic and economic outcomes, safety, and satisfaction in subjects with type 2 diabetes mellitus.

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Mar 2010

At a glance

  • Drugs Insulin glargine (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms INITIATE
  • Sponsors Sanofi
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 18 Jul 2007 Status change
    • 25 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top